Back to News
Federal RegisterFederal
Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
Plain English Summary
The Medicare Drug Price Negotiation Program is being officially established, along with new policies for the Medicare Prescription Drug Benefit Program. This change is part of the Inflation Reduction Act of 2022. Additionally, there will be updates to the rules regarding fixed combination drugs. Insurance agents should stay informed about these changes as they may affect how prescription drugs are covered under Medicare.
+View original text
This proposed rule would codify the Medicare Drug Price Negotiation Program ("Negotiation Program") and would establish certain new policies for the Negotiation Program and the Medicare Prescription Drug Benefit Program as required by the Inflation Reduction Act of 2022. This proposed rule would also propose a modification to the fixed combination drug policy.